Breaking News

FDA recalls heart drugs made by Teva, others over carcinogen impurity

The Food and Drug Administration issued a voluntary recall overdue Friday of high-blood power and center drugs containing the aspect valsartan on account of impurity problems. Affected companies include Teva Pharmaceuticals Industries Ltd. TEVA, -1.85% Solco Healthcare, and Major Pharmaceuticals, the FDA mentioned. The agency mentioned valsartan used in the affected merchandise contained N-nitrosodimethylamine, which is assessed as a probable human carcinogen. "We have carefully assessed the valsartan-containing medications sold in the United States, and we've found that the valsartan sold by these specific companies does not meet our safety standards," mentioned Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, in a observation.